Abhishek Gupta

Dr. Abhishek Gupta

School of Pharmacy and Life Sciences, University of Wolverhampton, Wolverhampton, UK
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2020 in Biomacromolecules
Verified
Journal Article
Open access
Abhishek GuptaAbhishek Gupta
Abhishek Gupta
SBSophie Marie Briffa
Sophie Marie Briffa
Sam SwinglerSam Swingler
Sam Swingler
HGHazel Gibson
Hazel Gibson
VKVinodh Kannappan
Vinodh Kannappan
Iza RadeckaIza Radecka
Iza Radecka
Chronic wounds are often recalcitrant to treatment due to high microbial bioburden and the problem of microbial resistance. Silver is a broad spectrum natural antimicrobial agent with wide applications extending to proprietary wound dressings. Recently silver nanoparticles have attracted attention in wound management. In the current study, the green synthesis of nanoparticles was accomplished using a natural reducing agent, curcumin which is a natural polyphenolic compound, well known as a wound healing agent. The hydrophobicity of curcumin was overcome by its microencapsulation in cyclodextrins. This prediction study demonstrates the production, characterisation of silver nanoparticles using aqueous curcumin:hydroxypropyl-β-cyclodextrin complex and loading them into bacterial cellulose hydrogel with moist wound healing properties. These silver nanoparticle-loaded bacterial cellulose hydrogels were characterised for wound management applications. In addition to high cytocompatibility, these novel dressings exhibited antimicrobial activity against three representative wound infecting pathogenic microbes Staphylococcus aureus, Pseudomonas. aeruginosa and Candida auris.

28 January 2021 in Polymers
Verified
Journal Article
Open access
PDF file
Sam SwinglerSam Swingler
Sam Swingler
Abhishek GuptaAbhishek Gupta
Abhishek Gupta
HGHazel Gibson
Hazel Gibson
Marek KowalczukMarek Kowalczuk
Marek Kowalczuk
Wayne HeaselgraveWayne Heaselgrave
Wayne Heaselgrave
Iza RadeckaIza Radecka
Iza Radecka
Bacterial cellulose (BC) is an extracellular polymer produced by Komagateibacter xylinus, which has been shown to possess a multitude of properties, which makes it innately useful as a next-generation biopolymer. The structure of BC is comprised of glucose monomer units polymerised by cellulose synthase in β-1-4 glucan chains which form uniaxially orientated BC fibril bundles which measure 3–8 nm in diameter. BC is chemically identical to vegetal cellulose. However, when BC is compared with other natural or synthetic analogues, it shows a much higher performance in biomedical applications, potable treatment, nano-filters and functional applications. The main reason for this superiority is due to the high level of chemical purity, nano-fibrillar matrix and crystallinity. Upon using BC as a carrier or scaffold with other materials, unique and novel characteristics can be observed, which are all relatable to the features of BC. These properties, which include high tensile strength, high water holding capabilities and microfibrillar matrices, coupled with the overall physicochemical assets of bacterial cellulose makes it an ideal candidate for further scientific research into biopolymer development. This review thoroughly explores several areas in which BC is being investigated, ranging from biomedical applications to electronic applications, with a focus on the use as a next-generation wound dressing. The purpose of this review is to consolidate and discuss the most recent advancements in the applications of bacterial cellulose, primarily in biomedicine, but also in biotechnology.

1 September 2019 in European Polymer Journal
Verified
Journal Article
Closed access
Abhishek GuptaAbhishek Gupta
Abhishek Gupta
DKD.J. Keddie
D.J. Keddie
VKV. Kannappan
V. Kannappan
HGH. Gibson
H. Gibson
IKI.R. Khalil
I.R. Khalil
IRI. Radecka
I. Radecka

1 January 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
KPKhatarina Meldawati Pasaribu
Khatarina Meldawati Pasaribu
SISyafruddin Ilyas
Syafruddin Ilyas
TTTamrin Tamrin
Tamrin Tamrin
Iza RadeckaIza Radecka
Iza Radecka
Sam SwinglerSam Swingler
Sam Swingler
SGSaharman Gea
Saharman Gea

18 November 2014 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
CMClaire Martin
Claire Martin
WLWan Li Low
Wan Li Low
Abhishek GuptaAbhishek Gupta
Abhishek Gupta
MAMohd Amin
Mohd Amin
IRIza Radecka
Iza Radecka
KKKen Kenward
Ken Kenward
Biofilms are formed by the attachment of single or mixed microbial communities to a variety of biological and/or synthetic surfaces. Biofilm micro-organisms benefit from many advantages of the polymicrobial environment including increased resistance against antimicrobials and protection against the host organism’s defence mechanisms. These benefits stem from a number of structural and physiological differences between planktonic and biofilm-resident microbes, but two main factors are the presence of extracellular polymeric substances (EPS) and quorum sensing communication. Once formed, biofilms begin to synthesise EPS, a complex viscous matrix composed of a variety of macromolecules including proteins, lipids and polysaccharides. In terms of drug delivery strategies, it is the EPS that presents the greatest barrier to diffusion for drug delivery systems and free antimicrobial agents alike. In addition to EPS synthesis, biofilm-based micro-organisms can also produce small, diffusible signalling molecules involved in cell density-dependent intercellular communication, or quorum sensing. Not only does quorum sensing allow microbes to detect critical cell density numbers, but it also permits co-ordinated behaviour within the biofilm, such as iron chelation and defensive antibiotic activities. Against this backdrop of microbial defence and cell density-specific communication, a variety of drug delivery systems have been developed to deliver antimicrobial agents and antibiotics to extracellular and/or intracellular targets, or more recently, to interfere with the specific mechanisms of quorum sensing. Successful delivery strategies have employed lipidic and polymeric-based formulations such as liposomes and cyclodextrins respectively, in addition to inorganic carriers e.g. metal nanoparticles. This review will examine a range of drug delivery systems and their application to biofilm delivery, as well as pharmaceutical formulations with innate antimicrobial properties such as silver nanoparticles and microemulsions.

13 January 2011 in Natural Product Research
Verified
Journal Article
Closed access
ADAbbas Delazar
Abbas Delazar
MDMohammad R. Delnavazi
Mohammad R. Delnavazi
Lutfun NaharLutfun Nahar
Lutfun Nahar
SMSadeigh B. Moghadam
Sadeigh B. Moghadam
MMMahdi Mojarrab
Mahdi Mojarrab
Satyajit SarkerSatyajit Sarker
Satyajit Sarker
Reversed-phase preparative HPLC analyses of the methanol extract of the aerial parts of Stachys lavandulifolia afforded a new phenylethanoid glycoside, 4,3′,4′-trimethoxy-lavandulifolioside A, named lavandulifolioside B, together with three other known phenylethanoid glycosides, lavandulifolioside A, verbascoside and leucosceptoside A, and an iridoid glycoside 5-O-β-allopyranosyloxy-aucubin (5-O-β-allopyranosyl-monomelittoside). While the structures of the known compounds, except the iridoid glycoside, were established by direct comparison of their spectroscopic data with respective literature data, lavandulifolioside B and 5-O-β-allopyranosyloxy-aucubin were identified comprehensively by extensive 1D and 2D NMR analyses. The distribution of the isolated compounds within the genus Stachys has been discussed.